Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Main inclusion criteria: 1. Diagnosis of small cell lung cancer. 2. Patients must have had one prior chemotherapy regimen which must have included either cisplatin or carboplatin. \[Additional eligibility criteria apply.\] Exclusion Criteria: * Prior radiotherapy that included \> 30% of the bone marrow (i.e., the whole of the pelvis or half of the spine). * Significant chronic or recent acute gastrointestinal disorder with diarrhea as a major symptom. * Significant heart disease. * Uncontrolled, untreated, unstable, or symptomatic brain tumors or central nervous system disease. * Grade 2+ peripheral neuropathy (a condition caused by damage to the nerves in the peripheral nervous system). \[Additional exclusion criteria apply.\]